HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William H Frishman Selected Research

Glucose (Dextrose)

5/2024Ninerafaxstat in the Treatment of Cardiometabolic Disease: Shifting Metabolic Paradigms.
9/2020Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2.
5/2020Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials.
5/2014The role of nonpharmacologic device interventions in the management of drug-resistant hypertension.
11/2012Renal sympathetic denervation for the treatment of systemic hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William H Frishman Research Topics

Disease

70Heart Failure
05/2024 - 03/2002
67Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 01/2003
51Hypertension (High Blood Pressure)
05/2024 - 01/2002
25Coronary Artery Disease (Coronary Atherosclerosis)
05/2024 - 07/2002
22Myocardial Infarction
11/2023 - 05/2003
21Inflammation (Inflammations)
05/2024 - 03/2005
20Atherosclerosis
05/2024 - 05/2004
18Stroke (Strokes)
02/2024 - 11/2002
16Obesity
05/2024 - 09/2006
15Thrombosis (Thrombus)
02/2024 - 11/2008
13Hemorrhage
05/2024 - 11/2008
13Myocardial Ischemia (Ischemic Heart Diseases)
07/2022 - 05/2003
11Atrial Fibrillation
05/2024 - 05/2003
10Diabetes Mellitus
11/2021 - 11/2002
9Coronary Disease (Coronary Heart Disease)
01/2024 - 09/2002
8Chronic Renal Insufficiency
04/2024 - 06/2015
8Cardiac Arrhythmias (Arrythmia)
03/2024 - 07/2003
8Infections
09/2023 - 07/2002
8ST Elevation Myocardial Infarction
03/2023 - 10/2013
7Acute Coronary Syndrome
01/2024 - 11/2008
7Dyslipidemias (Dyslipidemia)
11/2023 - 09/2004
7Cardiotoxicity
09/2023 - 03/2017
7Hyperlipidemias (Hyperlipidemia)
07/2022 - 09/2005
6Weight Loss (Weight Reduction)
05/2024 - 09/2006
6Type 2 Diabetes Mellitus (MODY)
05/2024 - 05/2020
6Cardiomyopathies (Cardiomyopathy)
02/2024 - 05/2003
6COVID-19
01/2024 - 05/2021
6Chronic Kidney Failure (Chronic Renal Failure)
03/2023 - 03/2005
6Neoplasms (Cancer)
10/2021 - 07/2016
5Cognitive Dysfunction
04/2024 - 07/2003
5Fibrosis (Cirrhosis)
03/2024 - 06/2004
5Hypercholesterolemia
01/2024 - 10/2002
5Migraine Disorders (Migraine)
10/2023 - 07/2002
5Atherosclerotic Plaque (Atheroma)
07/2023 - 05/2004
5Endocarditis
03/2023 - 09/2003
5Heart Diseases (Heart Disease)
09/2016 - 09/2002
4Pericarditis
05/2024 - 07/2023
4Alzheimer Disease (Alzheimer's Disease)
04/2024 - 01/2002
4Ventricular Tachycardia
03/2024 - 11/2014
4Heart Arrest (Cardiac Arrest)
02/2024 - 07/2014
4Transient Ischemic Attack
02/2024 - 03/2004
4Thromboembolism
02/2024 - 11/2013
4Hypertriglyceridemia
11/2023 - 09/2006
4Myocarditis (Carditis)
09/2023 - 05/2002
4Dementia (Dementias)
03/2023 - 01/2002
4Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
05/2014 - 03/2003
3Insulin Resistance
05/2024 - 07/2019
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024 - 05/2023
3Sepsis (Septicemia)
03/2024 - 11/2013
3Ischemic Stroke
02/2024 - 05/2003

Drug/Important Bio-Agent (IBA)

21Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2024 - 05/2003
13CholesterolIBA
04/2024 - 10/2002
13Antihypertensive Agents (Antihypertensives)IBA
02/2024 - 01/2002
12LipidsIBA
01/2024 - 09/2005
11AnticoagulantsIBA
02/2024 - 09/2003
10Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2019 - 05/2002
9DiureticsIBA
09/2023 - 05/2002
8Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2010
8Angiotensin Receptor AntagonistsIBA
01/2024 - 05/2002
7Hypoglycemic Agents (Hypoglycemics)IBA
04/2024 - 01/2003
7LDL CholesterolIBA
01/2024 - 03/2009
7oxidized low density lipoproteinIBA
09/2022 - 09/2005
7EnzymesIBA
11/2018 - 05/2004
6CalciumIBA
02/2024 - 11/2002
6CytokinesIBA
03/2022 - 01/2009
5Glucose (Dextrose)FDA LinkGeneric
05/2024 - 11/2012
5SaltsIBA
01/2024 - 01/2003
5Warfarin (Coumadin)FDA LinkGeneric
08/2023 - 05/2003
5LDL Lipoproteins (beta Lipoproteins)IBA
09/2022 - 09/2005
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
03/2022 - 05/2003
5Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
01/2020 - 01/2002
4IronIBA
05/2024 - 03/2014
4Oxygen (Dioxygen)IBA
05/2024 - 07/2016
4ColchicineFDA LinkGeneric
05/2024 - 09/2015
4SodiumIBA
04/2024 - 05/2012
4Biomarkers (Surrogate Marker)IBA
03/2024 - 09/2009
4VaccinesIBA
09/2023 - 09/2005
4Monoclonal AntibodiesIBA
07/2023 - 05/2014
4Calcium Channel Blockers (Blockers, Calcium Channel)IBA
09/2021 - 03/2003
4TroponinIBA
01/2021 - 03/2005
4HDL LipoproteinsIBA
11/2016 - 09/2005
4HDL CholesterolIBA
01/2014 - 09/2006
4Digoxin (Digitek)FDA LinkGeneric
05/2010 - 05/2002
3semaglutideIBA
05/2024 - 11/2022
3Interleukin-1 (Interleukin 1)IBA
05/2024 - 03/2022
3Protein Isoforms (Isoforms)IBA
04/2024 - 05/2009
3Indicators and Reagents (Reagents)IBA
04/2024 - 09/2017

Therapy/Procedure

85Therapeutics
05/2024 - 03/2002
21Drug Therapy (Chemotherapy)
01/2024 - 03/2002
11Percutaneous Coronary Intervention
03/2023 - 09/2008
8Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
11/2020 - 01/2007
7Stents
11/2023 - 05/2004
7Length of Stay
07/2016 - 12/2013
6Secondary Prevention
01/2024 - 05/2015
5Bariatric Surgery
01/2024 - 09/2006
5Defibrillators (Defibrillator)
12/2010 - 07/2009
4Catheters
11/2023 - 11/2012
3Glycemic Control
04/2024 - 09/2020
3Transcatheter Aortic Valve Replacement
04/2024 - 09/2019
3Cardiopulmonary Resuscitation (CPR)
02/2024 - 07/2014